HUMANIGEN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0002 USD | +100.00% |
|
-.--% | -83.33% |
| May. 01 | Combined Hearing for Disclosure Statement and Plan Approved for Humanigen, Inc. | CI |
| Apr. 12 | Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 11.91K | - | - | - | - | - | |
| 89.38B | ||||||
| 37.92B | ||||||
| 32.04B | ||||||
| 26.03B | ||||||
| 14.14B |
- Stock Market
- Equities
- HGENQ Stock
- Charts Humanigen, Inc.
- Sector Chart
